Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil - WF 97116
This study is to compare the safety and effects of donepezil (Aricept) or if it decreases memory loss after receiving chemotherapy for breast cancer.
Research Base: Wake Forest University Health Sciences
NCT ID: NCT02822573
NCI Protocol Number: WF-97116
For more information see ClinicalTrials.gov
Donepezil 5 mg; Placebo
Cognitive Dysfunction, Memory Impairment